SCHEMBL23916588

SCHEMBL23916588

C=Cc1cccc(N2CCN(C)CC2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 2/20 0.61
HTR3A P46098 1/20 0.50
AGXT P21549 1/20 0.50
ALDH1A1 P00352 2/20 0.47
HDAC3 O15379 2/20 0.46
HDAC4 P56524 2/20 0.46
HDAC1 Q13547 2/20 0.46
HDAC7 Q8WUI4 2/20 0.46
HDAC2 Q92769 2/20 0.46
HDAC10 Q969S8 2/20 0.46
HDAC11 Q96DB2 2/20 0.46
HDAC8 Q9BY41 2/20 0.46
HDAC6 Q9UBN7 2/20 0.46
HDAC9 Q9UKV0 2/20 0.46
HDAC5 Q9UQL6 2/20 0.46
TP53 P04637 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
GAA P10253 3/20 0.45
KDM4E B2RXH2 2/20 0.45
MAPT P10636 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL609803 0.91 TP53 (0.48) ADRA2CHTR3AALDH1A1TP53TDP1
SCHEMBL3584889 0.86 ADRA2C (0.61) ADRA2CHTR3AAGXTALDH1A1HDAC3
SCHEMBL607917 0.85 ALDH1A1 (0.47) ADRA2CAGXTALDH1A1TP53TDP1
SCHEMBL29442412 0.84 ALDH1A1 (0.64) ADRA2CHTR3AAGXTALDH1A1HDAC3
SCHEMBL1444185 0.84 ALDH1A1 (0.64) ADRA2CHTR3AAGXTALDH1A1HDAC3
SCHEMBL816394 0.84 PRMT6 (0.46) ADRA2CAGXTALDH1A1HDAC4TP53
SCHEMBL609136 0.84 PRMT6 (0.46) ADRA2CAGXTALDH1A1HDAC4TP53
SCHEMBL23048845 0.83 ADRA2C (0.57) ADRA2CHTR3AAGXTALDH1A1HDAC3
SCHEMBL12367112 0.81 TDP1 (0.42) ADRA2CALDH1A1TP53TDP1GAA
SCHEMBL4769361 0.81 LMNA (0.53) AGXTALDH1A1MAPTHTTABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3892276-A1 ISOQUINOLIN-3-YL CARBOXAMIDES AS WNT INHIBITORS BioSplice Therapeutics, Inc. (US) 2021-10-13 EP disclosed
US-9078909-B2 Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-07-14 US disclosed